Growth Metrics

Codexis (CDXS) Operating Income Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.69%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -347.04%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 80.62%
7 Evaxion A 64.16 Bn 64.14 Bn - 1.27%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,386.07%
10 Codexis 251.43 Mn 186.29 Mn 13.18 Mn 60.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 60.74%
Dec 31, 2025 243.84%
Sep 30, 2025 -14.45%
Jun 30, 2025 43.42%
Mar 31, 2025 -72.33%
Dec 31, 2024 -2,712.46%
Sep 30, 2024 48.36%
Jun 30, 2024 -80.04%
Mar 31, 2024 49.77%
Dec 31, 2023 102.12%
Sep 30, 2023 -201.43%
Jun 30, 2023 -383.94%
Mar 31, 2023 -182.20%
Dec 31, 2022 -27.59%
Sep 30, 2022 -899.70%
Jun 30, 2022 41.84%
Mar 31, 2022 8.40%
Dec 31, 2021 -164.65%
Sep 30, 2021 121.93%
Jun 30, 2021 26.54%
Mar 31, 2021 -16.97%
Dec 31, 2020 -314.36%
Sep 30, 2020 -2,441.31%
Jun 30, 2020 7.79%
Mar 31, 2020 -49.40%
Dec 31, 2019 -47.05%
Sep 30, 2019 112.30%
Jun 30, 2019 -72.56%
Mar 31, 2019 -11.30%
Dec 31, 2018 -173.18%
Sep 30, 2018 79.02%
Jun 30, 2018 39.44%
Mar 31, 2018 37.04%
Dec 31, 2017 116.76%
Sep 30, 2017 -807.76%
Jun 30, 2017 -381.77%
Mar 31, 2017 -7.09%
Dec 31, 2016 -135.11%
Sep 30, 2016 -75.08%
Jun 30, 2016 139.47%
Mar 31, 2016 -26.26%
Dec 31, 2015 -595.12%
Sep 30, 2015 233.73%
Jun 30, 2015 36.06%
Mar 31, 2015 13.56%
Dec 31, 2014 104.58%
Sep 30, 2014 53.82%
Jun 30, 2014 28.43%
Mar 31, 2014 33.58%
Dec 31, 2013 37.45%
Sep 30, 2013 -327.37%
Jun 30, 2013 -132.32%
Mar 31, 2013 -32.83%
Dec 31, 2012 -221.13%
Sep 30, 2012 7.59%
Jun 30, 2012 -1.27%
Mar 31, 2012 -114.56%
Dec 31, 2011 -1,466.77%
Sep 30, 2011 5.16%
Jun 30, 2011 -62.78%